These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2641007)

  • 21. Pharmacokinetic aspects of naloxone-precipitated morphine withdrawal in male and female prepubertal mice.
    Diaz SL; Hermida MP; Joannas LD; Olivera M; Ridolfi A; Villaamil EC; Balerio GN
    Biopharm Drug Dispos; 2007 Sep; 28(6):283-9. PubMed ID: 17570125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cyclic somatostatin analog that precipitates withdrawal in morphine-dependent mice.
    Shook JE; Pelton JT; Kazmierski W; Lemcke PK; Villar RG; Hruby VJ; Burks TF
    NIDA Res Monogr; 1987; 76():295-301. PubMed ID: 2893981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fractionated opiate withdrawal with tiapride and naloxone, a new treatment approach].
    Presslich O; Loimer N; Aschauer G; Fodor G; Pfersmann D; Müller K; Pakesch G; Lieber A
    Psychiatr Prax; 1989 Sep; 16(5):179-81. PubMed ID: 2798589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
    Zarrindast MR; Mohajeri S
    Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supersensitivity to naloxone following acute morphine pretreatment in humans: behavioral, hormonal and physiological effects.
    Higgins ST; Preston KL; Cone EJ; Henningfield JE; Jaffe JH
    Drug Alcohol Depend; 1992 Apr; 30(1):13-26. PubMed ID: 1591977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immune system and morphine dependence.
    Dafny N; Dougherty PM; Pellis NR
    NIDA Res Monogr; 1989; 95():293-5. PubMed ID: 2640972
    [No Abstract]   [Full Text] [Related]  

  • 27. Actions and addiction liabilities of alpha-acetylmethadols in man. 1952 [proceedings].
    Fraser HF; Isbell H
    NIDA Res Monogr; 1976 Jul; (8):58-2. PubMed ID: 995179
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of sublingually given naloxone in opioid-dependent human volunteers.
    Preston KL; Bigelow GE; Liebson IA
    Drug Alcohol Depend; 1990 Feb; 25(1):27-34. PubMed ID: 2323306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of precipitated abstinence in morphine- dependent rats.
    Wei E
    Psychopharmacologia; 1973; 28(1):35-44. PubMed ID: 4736632
    [No Abstract]   [Full Text] [Related]  

  • 30. Naloxone-precipitated acute opioid withdrawal syndrome after epidural morphine.
    Sun HL
    Anesth Analg; 1998 Mar; 86(3):544-5. PubMed ID: 9495411
    [No Abstract]   [Full Text] [Related]  

  • 31. [Apomorphine treatment of withdrawal symptoms in young opiate addicts].
    Gulmann NC; Kaldan B; Kobbernagal F
    Ugeskr Laeger; 1976 Oct; 138(42):2547-50. PubMed ID: 969008
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacotherapy of morphine addiction].
    Halbach H
    Bull Schweiz Akad Med Wiss; 1971 Jun; 27(1):15-21. PubMed ID: 5164917
    [No Abstract]   [Full Text] [Related]  

  • 33. Methadone maintenance in a patient on chronic hemodialysis.
    Glazer WM; Cohn GL
    Am J Psychiatry; 1977 Aug; 134(8):931-2. PubMed ID: 879364
    [No Abstract]   [Full Text] [Related]  

  • 34. Uncontrolled naloxone treatment.
    Dirksen R; Wood GJ; Nijhuis GM
    Lancet; 1981 Jun; 1(8232):1262-3. PubMed ID: 6112588
    [No Abstract]   [Full Text] [Related]  

  • 35. The naloxone conjunctival test in morphine addiction.
    Fanciullacci M; Boccuni M; Pietrini U; Sicuteri F
    Eur J Pharmacol; 1980 Feb; 61(3):319-20. PubMed ID: 7363943
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of the withdrawal syndrome in an opioid-dependent one-year-old child with decreasing pain.
    Rogers AG
    J Pain Symptom Manage; 1991 Apr; 6(3):129. PubMed ID: 2016557
    [No Abstract]   [Full Text] [Related]  

  • 37. Reversal of unconsciousness by use of naloxone in a profoundly mentally handicapped epileptic.
    Turner M; Stewart M
    J Ment Defic Res; 1991 Feb; 35 ( Pt 1)():81-4. PubMed ID: 1903814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heroin use in Vietnam and the united States. A contrast and a critique.
    Zinberg NE
    Arch Gen Psychiatry; 1972 May; 26(5):486-8. PubMed ID: 5019888
    [No Abstract]   [Full Text] [Related]  

  • 39. Pavlovian conditioning of drug reactions: some implications for problems of drug addiction.
    Lynch JJ; Fertziger AP; Teitelbaum HA; Cullen JW; Gantt WH
    Cond Reflex; 1973; 8(4):211-23. PubMed ID: 4747112
    [No Abstract]   [Full Text] [Related]  

  • 40. Naloxone: a safe and effective drug.
    Grufferman S; Rose R
    Ann Emerg Med; 1988 Jul; 17(7):764. PubMed ID: 3382087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.